ADKINS SEALE CAPITAL MANAGEMENT LLC
Position in GILD — Gilead Sciences, Inc.
CIK 2147212
SHREVEPORT, LA
Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$16,424
-$1,694 QoQ
Shares Held
130
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2,151
of 2,266 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADKINS SEALE CAPITAL MANAGEMENT LLC holds $2,847,531 across 11 Drug Manufacturers - General names. GILD ranks #9 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,914 | $994,038 | |
| 2 | AMGN |
Amgen Inc
|
1,768 | $640,228 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,509 | $450,906 | |
| 4 | LLY |
ELI LILLY & Co
|
263 | $315,450 | |
| 5 | NVO |
Novo Nordisk A S
|
2,891 | $138,594 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,803 | $103,888 | |
| 7 | NVS |
Novartis AG
|
641 | $100,457 | |
| 8 | PFE |
Pfizer Inc
|
2,511 | $60,464 |
All Filings in GILD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,424 | 130 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $18,118 | 130 | Shares | Sole | 2026-08-05 | |
| 2025-12-31 | $15,956 | 130 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||